Impact of obesity treatment on cardiometabolic health

Form Health provides overweight and obesity treatment that positively impacts cardiometabolic health outcomes.

Type 2 Diabetes: Mean Hemoglobin A1c improved from 9.0 to 6.2%, among those with the highest initial readings

Prediabetes (with Hemoglobin A1c ≥5.7%): 59% had normal Hemoglobin A1c
at last measure

Hyperlipidemia: 57% Stopped lipid-lowering medications

Hypertension: 50% Stopped antihypertensive medications

Elevated Liver Enzymes: 52% Experienced normalization in elevated liver function tests

Download the report to learn how Form Health total obesity and cardiometabolic care results in medical cost savings by improving, or even resolving, cardiometabolic conditions with weight loss.